Hartford Financial Management Inc. Sells 41 Shares of UnitedHealth Group Inc (NYSE:UNH)

Share on StockTwits

Hartford Financial Management Inc. trimmed its position in UnitedHealth Group Inc (NYSE:UNH) by 1.1% in the second quarter, according to its most recent filing with the SEC. The fund owned 3,761 shares of the healthcare conglomerate’s stock after selling 41 shares during the period. Hartford Financial Management Inc.’s holdings in UnitedHealth Group were worth $918,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. Garrison Point Advisors LLC raised its position in UnitedHealth Group by 1.2% during the 2nd quarter. Garrison Point Advisors LLC now owns 3,486 shares of the healthcare conglomerate’s stock worth $851,000 after purchasing an additional 40 shares during the last quarter. Integrated Investment Consultants LLC raised its position in UnitedHealth Group by 3.9% during the 2nd quarter. Integrated Investment Consultants LLC now owns 1,131 shares of the healthcare conglomerate’s stock worth $276,000 after purchasing an additional 42 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its position in UnitedHealth Group by 3.9% during the 1st quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 1,132 shares of the healthcare conglomerate’s stock worth $280,000 after purchasing an additional 43 shares during the last quarter. Meridian Financial Partners LLC raised its position in UnitedHealth Group by 2.7% during the 2nd quarter. Meridian Financial Partners LLC now owns 1,633 shares of the healthcare conglomerate’s stock worth $403,000 after purchasing an additional 43 shares during the last quarter. Finally, 1ST Source Bank raised its position in UnitedHealth Group by 3.0% during the 2nd quarter. 1ST Source Bank now owns 1,569 shares of the healthcare conglomerate’s stock worth $383,000 after purchasing an additional 45 shares during the last quarter. Institutional investors own 85.65% of the company’s stock.

In other news, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the transaction, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $241.99, for a total value of $2,419,900.00. Following the completion of the transaction, the director now owns 187,663 shares in the company, valued at approximately $45,412,569.37. The disclosure for this sale can be found here. Insiders sold a total of 37,000 shares of company stock worth $9,195,620 in the last 90 days. Company insiders own 0.82% of the company’s stock.

Several research analysts recently issued reports on UNH shares. Barclays lowered their target price on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research report on Wednesday, April 17th. Oppenheimer set a $312.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. SunTrust Banks lowered their price objective on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research report on Wednesday, April 17th. They noted that the move was a valuation call. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective for the company in a research report on Monday, July 22nd. Finally, UBS Group assumed coverage on UnitedHealth Group in a research report on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 price objective for the company. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $295.06.

Shares of UNH opened at $249.22 on Wednesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67. The company has a 50-day moving average price of $251.38. The firm has a market cap of $235.62 billion, a P/E ratio of 19.35, a PEG ratio of 1.33 and a beta of 0.61. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The company had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period last year, the business posted $3.14 EPS. Equities research analysts predict that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: What is total return in investing?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

BNP Paribas Analysts Give Hugo Boss  a €70.00 Price Target
BNP Paribas Analysts Give Hugo Boss a €70.00 Price Target
Commerzbank  Given a €6.50 Price Target by JPMorgan Chase & Co. Analysts
Commerzbank Given a €6.50 Price Target by JPMorgan Chase & Co. Analysts
DIC Asset  Given a €13.00 Price Target by Baader Bank Analysts
DIC Asset Given a €13.00 Price Target by Baader Bank Analysts
Berenberg Bank Analysts Give Vapiano  a €5.00 Price Target
Berenberg Bank Analysts Give Vapiano a €5.00 Price Target
UBS Group Reiterates “€130.00” Price Target for Continental
UBS Group Reiterates “€130.00” Price Target for Continental
Sanford C. Bernstein Analysts Give Total  a €64.00 Price Target
Sanford C. Bernstein Analysts Give Total a €64.00 Price Target


© 2006-2019 Ticker Report